ELREXFIO
We will be changing our web hosting provider during the next few days.
During this time, the site may work slowly or be unavailable.
We apologize for the inconvenience and kindly ask you to be patient!
Google image searchProduct monograph
Active ingredient
elranatamab, 44 MG/1.1 ML
DIN: 02543559
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription / Schedule D
Company: PFIZER CANADA ULC
Date: 23-JAN-2024
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
- L01FX32 — ELRANATAMAB (ATC/DDD)
Reference brand drug: Elrexfio
